| Literature DB >> 31820130 |
Ganna Degtiarova1,2, Piet Claus3, Jürgen Duchenne3,4, Marta Cvijic4, Georg Schramm1, Johan Nuyts1, Jens-Uwe Voigt3,4, Olivier Gheysens5,6.
Abstract
BACKGROUND: In order to better understand the concept of mechanical dyssynchrony, a promising hallmark of cardiac resynchronization therapy (CRT) response, we investigated its effect on regional myocardial metabolism and myocardial blood flow (MBF) in non-ischemic CRT candidates.Entities:
Keywords: Cardiac resynchronization therapy; Mechanical dyssynchrony; Metabolism; Perfusion; Positron emission tomography
Year: 2019 PMID: 31820130 PMCID: PMC6901655 DOI: 10.1186/s13550-019-0575-9
Source DB: PubMed Journal: EJNMMI Res Impact factor: 3.138
Clinical characteristics of patients
| Parameter | All patients ( | With mechanical dyssynchrony ( | Without mechanical dyssynchrony ( | |
|---|---|---|---|---|
| Clinical characteristics: | ||||
| Male (% of total) | 16 (53%) | 10 (43%) | 6 (86%) | 0.05 |
| Age (years) | 68 ± 10 | 68 ± 9 | 68 ± 12 | 0.94 |
| Diabetes mellitus (% of total) | 4 (13%) | 3 (13%) | 1 (14%) | 0.93 |
| Systolic blood pressure (mmHg) | 134 ± 22 | 134 ± 21 | 120 ± 28 | 0.18 |
| Diastolic blood pressure (mmHg) | 69 ± 15 | 70 ± 14 | 65 ± 17 | 0.47 |
| NYHA class II/III: | 17 (57%)/13 (43%) | 12 (52%)/11 (48%) | 5 (71%)/2 (29%) | 0.42 |
| Electrocardiographic parameters: | ||||
| QRS width (ms) | 161 ± 16 | 161 ± 15 | 163 ± 21 | 0.73 |
| LBBB (Strauss) | 25 (83%) | 21 (91%) | 4 (57%) | 0.03 |
| RV pacing | 1 (3%) | 0 (0%) | 1 (14%) | 0.23 |
| NS-IVCD | 4 (10%) | 2 (9%) | 2 (29%) | 0.21 |
| Echocardiographic parameters (pre-CRT): | ||||
| EDV (ml) | 142 [133;193] | 142 [126;203] | 164 [116;202] | 0.88 |
| ESV (ml) | 100 [91;138] | 98 [85;147] | 101 [76;138] | 0.74 |
| EF (%) | 32 ± 8 | 32 ± 9 | 32 ± 5 | 0.99 |
| Heart failure therapy: | ||||
| β-blockers | 26 (87%) | 19 (83%) | 7 (100%) | 0.54 |
| ACEi/ARB | 27 (90%) | 21 (91%) | 6 (86%) | 0.66 |
| Aldosterone antagonists | 17 (57%) | 13 (57%) | 4 (57%) | 0.9 |
ACEi angiotensin-converting enzyme inhibitors, ARB angiotensin-receptor blockers, EDV end-diastolic volume, ESV end-systolic volume, LBBB left bundle branch block, RV right ventricle, NS-IVCD non-specific intraventricular conduction delay
Fig. 1Regional glucose metabolism and myocardial blood flow (MBF). Regional glucose metabolism (18F-FDG uptake) (a) and MBF (b) in patients with and without mechanical dyssynchrony. SEPT, septum; LAT, lateral wall. ***p ≤ 0.0001
Fig. 2Correlation plots between myocardial work versus glucose metabolism and perfusion. Correlation between myocardial work and glucose metabolism (18F-FDG) (a) and myocardial work and MBF (b), measured in the septum and lateral wall in patients with and without mechanical dyssynchrony
Fig. 3Representative example of the regional glucose metabolism, MBF, and workload. The figure shows lower septal compared with the lateral wall glucose metabolism, MBF, and workload in a patient with mechanical dyssynchrony and relatively homogeneous glucose metabolism, MBF, and workload in a patient without mechanical dyssynchrony
Fig. 4Correlation plots between volumetric reverse remodeling versus 18F-FDG and MBF SLRs. Correlation plot between 18F-FDG SLR versus Δ LV ESV (a) and MBF SLR versus Δ LV ESV (b) in patients with and without mechanical dyssynchrony